. | Urine M-spike . | Urine total protein . | ||||
---|---|---|---|---|---|---|
Overall population . | Normal renal function . | Abnormal renal function . | Overall population . | Normal renal function . | Abnormal renal function . | |
Urine-only patients plus serum and urine patients, n | 101 | 81 | 20 | 148 | 119 | 29 |
iFLC | .60 (<.001) | .67 (<.001) | .55 (.01) | .48 (<.001) | .48 (<.001) | .62 (<.001) |
dFLC | .60 (<.001) | .66 (<.001) | .61 (.004) | .46 (<.001) | .47 (<.001) | .55 (.002) |
rFLC | .40 (.001) | .43 (<.001) | .27 (.3) | .32 (.003) | .30 (.001) | .42 (.003) |
Urine-only patients, n | 32 | 26 | 6 | 37 | 32 | 5 |
iFLC | .58 (<.001) | .69 (.001) | .49 (.3) | .51 (.001) | .54 (.002) | .70 (.2) |
dFLC | .58 (<.001) | .69 (.001) | .49 (.3) | .51 (.001) | .54 (.001) | .70 (.2) |
rFLC | .54 (.002) | .61 (.001) | .31 (.5) | .55 (<.001) | .54 (.001) | .70 (.2) |
Serum and urine patients, n | 69 | 55 | 14 | 111 | 87 | 24 |
iFLC | .62 (<.001) | .65 (<.001) | .58 (.03) | .49 (<.001) | .48 (<.001) | .62 (.001) |
dFLC | .62 (<.001) | .64 (<.001) | .62 (.02) | .49 (<.001) | .46 (<.001) | .53 (.007) |
rFLC | .37 (.002) | .38 (.004) | .28 (.3) | .28 (.003) | .25 (.02) | .37 (.08) |
. | Urine M-spike . | Urine total protein . | ||||
---|---|---|---|---|---|---|
Overall population . | Normal renal function . | Abnormal renal function . | Overall population . | Normal renal function . | Abnormal renal function . | |
Urine-only patients plus serum and urine patients, n | 101 | 81 | 20 | 148 | 119 | 29 |
iFLC | .60 (<.001) | .67 (<.001) | .55 (.01) | .48 (<.001) | .48 (<.001) | .62 (<.001) |
dFLC | .60 (<.001) | .66 (<.001) | .61 (.004) | .46 (<.001) | .47 (<.001) | .55 (.002) |
rFLC | .40 (.001) | .43 (<.001) | .27 (.3) | .32 (.003) | .30 (.001) | .42 (.003) |
Urine-only patients, n | 32 | 26 | 6 | 37 | 32 | 5 |
iFLC | .58 (<.001) | .69 (.001) | .49 (.3) | .51 (.001) | .54 (.002) | .70 (.2) |
dFLC | .58 (<.001) | .69 (.001) | .49 (.3) | .51 (.001) | .54 (.001) | .70 (.2) |
rFLC | .54 (.002) | .61 (.001) | .31 (.5) | .55 (<.001) | .54 (.001) | .70 (.2) |
Serum and urine patients, n | 69 | 55 | 14 | 111 | 87 | 24 |
iFLC | .62 (<.001) | .65 (<.001) | .58 (.03) | .49 (<.001) | .48 (<.001) | .62 (.001) |
dFLC | .62 (<.001) | .64 (<.001) | .62 (.02) | .49 (<.001) | .46 (<.001) | .53 (.007) |
rFLC | .37 (.002) | .38 (.004) | .28 (.3) | .28 (.003) | .25 (.02) | .37 (.08) |